Prosecutors have been issuing subpoenas to pharmaceutical and digital health companies to probe the role of generative technology in potential anti-kickback and false claims violations.
The prosecutors are specifically looking at how EHR vendors are incorporating advanced AI tools to connect patients with specific drugs and devices. According to the news outlet, GSK, AstraZeneca and Merck have disclosed receiving subpoenas related to electronic medical records, but resolutions with the Justice Department have not been announced.
Anonymous sources say that the Justice Department’s attorneys are in the early stages of asking general questions and may still be formulating a strategy.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
